Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
It is intended strictly for in-vitro laboratory research use only
For patients who do not adequately achieve good glycaemic control or show contraindication to the above-mentioned drugs, insulin treatment should be suggested, first as long-acting insulin and after as a basal-bolus scheme ( Figure 2 )
Product Specifications Synonyms: LY3298176, P1206, tirzepatida, tirzepatidum CAS Number: 2023788-19-2 Molecular Formula: CHNO Molecular Weight: 4813.48 g/mol Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH Purity: 95% (verified by HPLC and mass spectrometry) Packaging Format: 10 mg lyophilized powder in a sealed research-grade vial Storage Conditions: Store 28 C (20 C long term)
doi:10.1002/ajh.24088
The information provided here should not replace advice from a medical professional.
US$ 29.26
US$ 23.33
US$ 28.35
US$ 20.95
US$ 28.94
US$ 26.59
US$ 25.30
US$ 20.39
US$ 27.19
US$ 23.48
US$ 22.01
US$ 27.89
